Flavonoid Structure-Activity Studies Identify 6-Prenylchrysin and Tectochrysin as Potent and Specific Inhibitors of Breast Cancer Resistance Protein ABCG2
- 1 June 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (11) , 4852-4860
- https://doi.org/10.1158/0008-5472.can-04-1817
Abstract
Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 μmol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 μmol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 μmol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.Keywords
This publication has 41 references indexed in Scilit:
- Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognitionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- Inorganic and organic phosphate measurements in the nanomolar rangePublished by Elsevier ,2004
- ABCG2 – a transporter for all seasonsFEBS Letters, 2004
- Interaction of the breast cancer resistance protein with plant polyphenolsBiochemical and Biophysical Research Communications, 2004
- Functional Characterization of Human Breast Cancer Resistance Protein (BCRP, ABCG2) Expressed in the Oocytes of Xenopus laevisMolecular Pharmacology, 2003
- Microplate Screening of the Differential Effects of Test Agents on Hoechst 33342, Rhodamine 123, and Rhodamine 6G Accumulation in Breast Cancer Cells that Overexpress P–GlycoproteinSLAS Discovery, 2002
- Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect CellsBiochemical and Biophysical Research Communications, 2001
- Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoproteinPublished by Elsevier ,2001
- Essential Dynamics from NMR Clusters: Dynamic Properties of the Myb DNA-Binding Domain and a Hinge-Bending Enhancing VariantMethods, 1998
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992